Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

Autor: Clotet, Bonaventura, Bellos, Nicholas, Molina, Jean-Michel, Cooper, David, Goffard, Jean-Christophe, Lazzarin, Adriano, Wöhrmann, Andrej, Katlama, Christine, Wilkin, Timothy, Haubrich, Richard, Cohen, Calvin, Farthing, Charles, Jayaweera, Dushyantha, Markowitz, Martin, Ruane, Peter, Spinosa-Guzman, Sabrina, Lefebvre, Eric
Zdroj: In The Lancet 2007 369(9568):1169-1178
Databáze: ScienceDirect